Snapchat allows drug dealers to operate openly on platform, finds Danish study
Snapchat has been accused by a Danish research organisation of leaving an “overwhelming number” of drug dealers to openly operate on Snapchat, making it easy for children to buy substances including cocaine, opioids and MDMA.The social media platform has said it proactively uses technology to filter out profiles selling drugs.However, research by Digitalt Ansvar (Digital Accountability), a Danish research organisation that promotes responsible digital development, has found evidence of a failure to moderate drug-related language in usernames.It also accused Snapchat of failing to respond adequately to reports of profiles openly selling drugs.Researchers used profiles of 13-year-olds and found a multitude of people selling drugs on Snapchat under usernames featuring keywords such as “coke”, “weed” and “molly”.
When researchers reported 40 of these profiles to Snapchat, the company removed only 10 of them.The other 30 reports were rejected, they said.Snapchat said it had “proactively disabled” 75% of the accounts reported and had now disabled all of them.The investigation also found that despite previous criticism, Snapchat’s recommendation systems were spreading and promoting profiles of those selling illegal drugs to users – including to children who had not previously shown an interest in or interacted with drug-dealing profiles.Within a few hours, the researchers’ 13-year-old test profiles had recommendations to add up to 70 suspected drug-dealing profiles because one friend was connected to a drug-dealing profile.
Digitalt Ansvar’s CEO, Ask Hesby Holm, said: “As a child or young person, you don’t need to search for these profiles yourself; you can have them recommended directly by Snapchat.That is deeply problematic.“Snapchat itself says they proactively use technology to filter out profiles that sell drugs on the platform.Our investigation shows this is not true.Snapchat hosts an overwhelming number of openly drug-related profiles and appears not to moderate either implicit or explicit drug-related language in usernames.
” This failure to moderate profiles with such obvious usernames, he said, meant that “children and young people have very easy access to buying drugs on Snapchat”.He added: “It’s not technology that’s lacking, it is will.Snapchat can easily filter such usernames.”According to Snapchat, in 2023 it had a 90% reach of 13- to 24-year-olds in the Nordics.Digitalt Ansvar accused Snapchat of breaking EU rules for digital services on the protection of children and called for authorities to act.
Sign up to This is EuropeThe most pressing stories and debates for Europeans – from identity to economics to the environmentafter newsletter promotionA Snapchat spokesperson said: “We have zero tolerance for drug sales on Snapchat,Even though the accounts flagged in the study were not all reported in-app, more than 75% of those accounts had already been disabled by our teams before we were made aware of this report, and all accounts now have been,“At Snapchat, we are working diligently and have invested tremendous resources to stop drug dealers from abusing our platform,We deploy proactive detection to identify and disable these accounts, support law enforcement to bring dealers to justice, and educate our community about the dangers of drugs,Over the past year, we have proactively consulted law enforcement across Europe to identify new search terms and emojis used by criminals, aiming to enhance our proactive detection and maintain a hostile environment to drug dealers.
”
Pound dips after UK economy doesn’t grow in July; Ocado shares slide 20% amid robotic warehouses demand fears – as it happened
The pound has weakened since today’s GDP report showed the UK economy failed to grow in July.Sterling is down 0.2% at $1.355 against the US dollar this morning.Kathleen Brooks, research director at XTB, points out there is “not much to like” from the July monthly GDP update, with zero growth in the economy at the start of the third quarter
Barclays boss urges UK ministers to limit public sector pay rises
The chief executive of Barclays has said the UK government needs to limit pay rises for public sector workers and resist a further “squeeze” on banks with tax increases.CS Venkatakrishnan said the government needed to look at its own spending levels as the chancellor, Rachel Reeves, seeks ways to address a fiscal hole when she announces her budget in November.“We need to curb expenditure at the government level,” he told the Financial Times. “We need to find a way to curb wage inflation.”Venkatakrishnan said that while the government needed to restrict rising “public sector” wages, the inflationary impact of pay rises was an issue across the UK economy
UK economy flatlines in July in grim news for Rachel Reeves
The UK economy flatlined in July, according to official figures, in grim news for Rachel Reeves as she gears up for a challenging budget.It was a slowdown compared with June, when the economy grew by 0.4%, according to the Office for National Statistics.GDP expanded strongly in the first half of the year, making the UK the fastest-growing economy in the G7, but it had been widely expected to slow in the second half.The ONS said that growth in the services and construction sectors in July was offset by a 0
Stagnant GDP shows scale of challenge for Rachel Reeves at autumn budget
“Our economy isn’t broken, but it does feel stuck,” is the message from Rachel Reeves.Having made rebooting the economy the No 1 priority for government, it is a brutally honest assessment from a chancellor more than a year into the job.The latest GDP figures, released on Friday, highlight the scale of the challenge for Reeves at her autumn budget. Growth flatlined in July, slowing from 0.4% in June, as the economy struggled for momentum over the summer
Britain is ‘a terrible place’ to sell medicines, says drug firm executive
A senior pharmaceuticals executive has called on the government to come up with a “proper” roadmap for raising spending on new medicines, saying Britain is “not a good place” to develop or sell drugs.Paul Naish, the UK head of market access for the French company Sanofi, said Britain was “at a critical point”.He added: “We’ve still got the best universities, we’ve got some of the best scientists in the world, but it’s not a good place to do the development work for medicines. It’s an expensive place to operate, and it’s a terrible place to sell medicines.”The drugmaker MSD, known as Merck in the US, this week ditched its under-construction £1bn research centre in London
Business rates rise would put hundreds of big shops at risk, say UK retailers
Up to 400 large shops are at risk of closure with as many as 100,000 jobs at risk if the government goes ahead with plans to hit stores with higher business rates, retailers have warned.Some of the UK’s largest retail premises, including supermarkets and department stores, would face higher property tax charges under new rules being considered by the government before November’s budget.The higher charges for larger sites, including warehouses, offices and other premises, are intended to pay for discounts for smaller business properties, such as independent retailers, cafes and pubs, after the Labour government pledged to make the business rates system fairer.The bosses of big retailers including John Lewis, Lidl and B&Q met the chancellor, Rachel Reeves, last week to ask her to exclude retail from the surcharge.The new rules are targeted at all business premises with a rateable value – a figure linked to rents – of more than £500,000
Hundreds of prison officers may have to leave UK after Labour’s visa rule change
Children detained under Mental Health Act held for hours in A&E departments
Hospices ‘on the brink’ financially if assisted dying is legalised
Cost of place in children’s care homes in England hits almost £320,000 a year
Girls who play after-school sport in UK 50% more likely to later get top jobs, study finds
Boom times and total burnout: three days at Europe’s biggest pornography conference